Shares of Oncimmune Holdings plc (LON:ONC – Get Free Report) dropped 11.7% during trading on Tuesday . The stock traded as low as GBX 12.50 ($0.16) and last traded at GBX 12.50 ($0.16). Approximately 250,390 shares were traded during trading, an increase of 135% from the average daily volume of 106,670 shares. The stock had previously closed at GBX 14.15 ($0.18).
Oncimmune Stock Performance
The business’s 50-day simple moving average is GBX 15.15 and its two-hundred day simple moving average is GBX 14.66. The company has a quick ratio of 0.63, a current ratio of 1.13 and a debt-to-equity ratio of 806.85. The firm has a market cap of £9.56 million, a price-to-earnings ratio of -430.00 and a beta of 1.19.
About Oncimmune
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
See Also
- Five stocks we like better than Oncimmune
- What Are Dividends? Buy the Best Dividend Stocks
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- Following Congress Stock Trades
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.
